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Abstract
Background: Although a laparoscopic cholecystectomy (LC) is the gold standard treatment for symp-
tomatic cholelithiasis, its safety and efficacy in the morbidly/super obese patients is unknown. The aim
of this study was to investigate the safety and efficacy of an elective LC in the morbid/super obese
patients.
Methods: A retrospective review of the hospital electronic database and medical records was
conducted searching for all elective LC from 2010 to 2013. The data collected included patient
demographics and body mass index (BMI), length of hospital stay (LOS), duration of surgery (DOS),
intra- and post-operative complications, bile duct injuries, performance of an intra-operative cholangio-
gram, the incidence of open conversion and the seniority of the operator.
Results: A total of 799 patients (76% female) with a mean age of 46 years and BMI of 31 were
included in this study. There were significant differences in the median DOS between the three BMI
groups; BMI < 26 [64 min; interquartile range (IQR) 54–83]; BMI 26–40 (72 min, IQR 58–91) and BMI
> 40 (82 min, IQR 63–104), P < 0.001. There were no statistically significant differences in the LOS,
peri-operative complication rates, open conversions or bile duct injuries among the BMI groups.
Conclusions: This study showed that LC can be performed safely in the morbid/super obese patients.
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Introduction
A laparoscopic cholecystectomy (LC) has been established as
the gold standard treatment for symptomatic cholelithiasis.
Numerous large series has proven the safety and efficacy of this
procedure. The overall morbidity and mortality rate is 5–10%
and 0.1% respectively, and an open conversion rate of 5–10%
is commonly reported.1–3
One of the risk factors for cholelithiasis is obesity, the inci-
dence of which is increasing worldwide. 4 Therefore, surgeons
are increasingly likely to encounter a growing number of obese
patients who require a cholecystectomy for symptomatic chole-
lithiasis. Traditionally obesity has been considered a relative
contraindication to LC, as the technical difficulties associated
with this procedure in these patients were thought to be asso-
ciated with higher morbidity and mortality as well as increased
open conversion rates.5
However, with increasing experience in laparoscopic surgery
and the development of better instruments, the practice of LC in
the obese patients is growing. Several recent studies have
reported that LC is feasible and can be safely performed in the
obese patients.6–8 These studies have shown that obesity was not
associated with higher complication or open conversion rates,
and the length of hospital stay (LOS) was equivalent when com-
pared to the non-obese patients. The only consistently reported
difference in the literature between the two groups of patients
was a longer operating time in the obese patients.
Although there is growing evidence on the safety and effi-
cacy of LC in the obese patients, there is a lack of data on its
use in the morbid/super obese [body mass index (BMI) > 40]
patients. A review of the literature found only one study which
compared laparoscopic to open cholecystectomy in patients
with BMI > 50.9 Laparoscopic surgery was found to be associ-
ated with a shorter operating time and LOS, as well as reduced
peri-operative complication rates.
The purpose of this study was to investigate the safety [peri-
operative morbidity and mortality and the incidence of bile
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duct injuries (BDI)] and efficacy (duration of surgery, LOS
and open conversion rates) of an elective LC in the morbid/
super obese patients (BMI > 40) compared to patients with a
BMI < 26 and a BMI 26–40.
Methods
A review of a prospectively maintained electronic database and
the medical records for all elective LC performed from July
2010 to September 2013 at a teaching hospital in Adelaide,
South Australia was undertaken. The data collected include
patient demographics and BMI, LOS, duration of surgery
(DOS), intra- and post-operative complications, bile duct inju-
ries, performance of an intra-operative cholangiogram, the
incidence of open conversion and the seniority of the operator.
The patients were divided into three groups: BMI < 26, BMI
26–40 and BMI > 40. The LOS was calculated from the day of
admission until discharge while the duration of surgery was
from the initiation of skin incision to the end of skin closure.
Any occurrence of intra-operative complications and/or con-
version to open surgery was documented. After discharged
from the hospital the patients were regularly followed-up in
the outpatient clinic between 4 and 8 weeks, therefore allowing
assessment of morbidity and mortality up to 30-days. Post-
operative complications were graded according to the Dindo–
Clavien10 classification, and bile ducts injuries according to the
Strasberg11 classification, respectively. The operators were
divided into three groups: consultant surgeons, fellows with a
fellowship from theRoyal Australasian College of Surgeons or
equivalent qualification or surgical trainees in a 5-year General
Surgery training programme.
The LC technique used at the authors’ institution consists of
a standard four trocars approach. An open cut down technique
is used to create a pneumoperitoneum, usually starting in the
peri-umbilical area where a 12-mm port is used for the laparo-
scopic camera. In the obese patients, the camera port is usually
placed supra-umbilically in closer proximity to the gallbladder,
and additional trocars may need to be inserted to assist with
retraction of the liver, omentum and/or bowel loops as
required. Patients were positioned in steep reverse Trendelen-
burg to help displace the omentum and bowel loops caudally
and improve operative vision; a broad holding strap was rou-
tinely placed across the patient’s thighs to prevent slippage off
the bed during the operation. A 30° camera was used as
required. A 10-mm epigastric port and two 5-mm right
abdominal ports are placed under vision for instrumentation.
The gallbladder fundus is retracted cephaladly and dissection
using diathermy is started in the Calot’s triangle to expose the
cystic artery and the cystic duct. An intra-operative cholangio-
gram was performed at the surgeons’ discretion. The cystic
duct and artery is then divided between clips, and the gallblad-
der dissected off the liver in a retrograde fashion. The gallblad-
der is then removed through either the umbilical or the
epigastric port in an endoscopic retrieval bag. The umbilical
fascia and skin is closed with suture; the surgical incisions
infiltrated with local anaesthesia. The patients are charted for
regular analgesia (paracetamol, NSAIDs, opioids) and anti-
emetics (metoclopramide, ondansetron). Patients undergoing
LC at the authors’ institution were generally admitted for an
overnight stay, until the implementation of an ambulatory sur-
gery protocol in mid-2011.
The exclusion criteria for this study included: acute chole-
cystitis, gallbladder neoplasm, open cholecystectomy and a
combined procedure, e.g. repair of an inguinal hernia in con-
junction with a LC.
Statistical analysis
Continuous outcomes (LOS and DOS) were tested using
ANOVA, whereas categorical outcomes (open conversion,
intra- and post-operative complications, and bile duct injuries)
were tested using Fisher’s exact test. To test for differences in
LOS (days) between BMI groups, LOS (days) was transformed
by raising to the power of 0.4 owing to non-normality of
the residuals in the model using raw data: los_transformed
= los0.4. An ANOVA was then fitted to the data with trans-
formed LOS as the outcome and BMI group as the indepen-
dent variable. Logistic regression models were used to calculate
the odds ratio to compare BMI groups for open conversion,
intra- and post-operative complication and bile duct injuries.
A P < 0.05 was considered a statistically significant result.
Results
A total of 799 consecutive patients who underwent elective LC
between July 2010 and Sept 2013 were included in this study.
The patient demographics and BMI data are shown in Table 1.
An intra-operative cholangiogram was performed in 661
patients (83%) with no significant differences between the vari-
ous BMI groups.
The overall median duration of surgery was 70 min [inter-
quartile range (IQR) 56–91], with the procedure taking pro-
gressively longer to perform as the BMI increases (Table 2).
Peri-operative outcomes by BMI group are shown in Table 2.
There were four (0.5%) patients who required conversion to
open surgery. Three of the open conversions were as a result
of dense adhesions precluding safe laparoscopic surgery, and









Female, n (%) 131 (77) 412 (74.5) 65 (85.5) 608 (76.1)
Mean age,
year (SD)
46.8 (19.8) 46.7 (15.6) 40.6 (13.1) 46 (16.4)
Mean BMI (SD) 22 (2.4) 32 (4.0) 46 (5.0) 31 (7.2)
BMI, body mass index.
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one was because of the inability to dissect safely in the Calot’s
triangle.
There were 18 (2.3%) patients who had intra-operative com-
plications; however, there were no statistically significant differ-
ences between the groups. Twelve of the 18 intra-operative
complications were as a result of bleeding from a minor hepatic
laceration and capsular tears; bleeding in eight patients was con-
trolled successfully with just using diathermy, whereas an addi-
tional interventions were required in four patients [Surgicel
(Ethicon) and/or Floseal (Baxter)]. One patient had an iatro-
genic injury to the common hepatic duct discovered intra-opera-
tively which was managed with a T-tube. The other intra-
operative complications included a faulty instrument causing
prolonged surgery, spillage of gallstones intra-operatively which
were subsequently lost, intra-operative tachycardia requiring
pharmacological cardioversion and a severe allergic reaction to
anaesthetic agents during induction causing hypotension.
There were 4 (0.5%) patients who suffered biliary injuries
with no statistically significant differences between each of the
BMI groups. Three patients were found to have bile leaks from
the cystic duct stumps and the gallbladder bed. These patients
were returned to theatre for washout and re-clipping of the
cystic duct stump and placement of drains in the Morrison’s
pouch. One patient was discovered to have an iatrogenic injury
to the common hepatic duct intra-operatively and hence a
T-tube was placed. All patients recovered satisfactorily without
further significant complications.
Overall post-operative complications occurred in 38 (4.8%)
patients, with no significant differences between each of the
BMI groups (Table 3).
Twenty patients (2.5%) were re-admitted after discharge for
various reasons, mostly as a result of inadequately controlled
pain (n = 8) and superficial wound infections (n = 5).
Sub-group analysis adjusting for the operator showed no
statistically significant differences in any of the parameters
between each of the BMI groups, except for the duration of
surgery where consultant surgeons and fellows took a median
of 11 and 10 min, respectively, less than the registrars to com-
plete the operation (P < 0.001).
Discussion
This study shows that a LC can be performed in the morbid/
super obese patients safely and efficiently with equally good
outcomes when compared to patients with a normal BMI. The
incidence of intra-operative complications was low, ranging
from 1% to 2% across the different BMI groups. The overall
post-operative complication (n = 6/76; 7.9%) rates in the BMI
> 40 groups were higher than the other two BMI groups but
the differences were not statistically significant. There was no
biliary injury or death in the BMI > 40 group. LC in the BMI
> 40 group took on a median of 18 and 10 min longer to per-
form compared to the BMI < 26 and BMI 26–40 groups,
respectively. This reflects the more challenging and difficult
surgery associated with LC in these groups of patients. How-
ever, despite this, there were no significant differences in the
open conversion rates or the median duration of hospital stay
which was essentially identical (1.1 days) among the groups.
The results of this study compare favourably with other fig-
ures published in the literature. The mean LOS in this study
was 1.5 (SD 2.6) days, compared to 2–4 days published in sim-
ilar studies.6,8,12 The mean operating time was 75 (SD
28) min, compared to 46–98 min from other authors.6,8,12,13
The overall conversion rate in this study was 0.5%, as com-
pared to 7.7%,8 4.2%,6 and 4.1%.12 The often quoted conver-
sion rate in the recent literature is approximately 5–8%.1,2 The
intra- and post-operative complication rates reported in this
study were lower compared to others published in the litera-
ture. Ammori et al.7 reported their intra- and post-operative
complication rates of 17.6% and 11.8%, respectively, in the
morbidly obese patients, compared to 2.3% and 4.9% in this
study. Likewise the re-admission rate in this study (2.5%)
compares well to the 2–10% normally quoted in the litera-
ture.1,3,14 The authors believed that one of the main reason for
Table 2 Peri-operative outcomes according to different body mass index (BMI) groups
BMI <26 n = 170 BMI 26–40 n = 553 BMI >40 n = 76 Total N = 799 P-value
Median DOS, min (IQR) 64 (54–83) 72 (58–92) 82 (63–104) 70 (56–91) <0.001
Median LOS, days (IQR) 1.1 (1.0–1.3) 1.1 (1.0–1.3) 1.1 (1.0–1.3) 1.1 (1.1–1.3) 0.269
Conversion, n (%) 1 (0.6) 2 (0.4) 1 (1.3) 4 (0.5) 0.244
Post-op complications, n (%) 8 (4.7) 25 (4.5) 6 (7.9) 39 (4.9) 0.411
Biliary complications, n (%) 0 (0) 4 (0.7) 0 (0) 4 (0.5) 0.718
Cholangiogram, n (%) 143 (84) 457 (83) 61 (80) 661 (83) –
Operator, n (%)
Consultant 114 (67) 361 (65) 52 (68) 527 (66) 0.820
Fellow 21 (12) 86 (16) 11 (15) 118 (15)
Registrar 35 (21) 106 (19) 13 (17) 154 (19)
DOS, duration of surgery; LOS, length of hospital stay.
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the favourable results reported in this study was the surgeons’
increasing experience with operating in the morbid and super
obese patients. Other factors such as better laparoscopic equip-
ment and improved anaesthetic and peri-operative care of the
obese patients are also major contributions. It must also be
noted that 15–20% of the patients reported in these other
studies had acute cholecystitis, a possible explanation for
higher open conversion and complication rates compared to
this study.
The authors acknowledge several limitations inherent to all
retrospective studies, as is the case with the current study.
First, a prospective study could have allowed a more systematic
collection of data such as the ASA grade and patient co-mor-
bidities which would have provided useful information for
clinical practice. Although this study has established the safety
and efficacy of LC in the morbid/super obese patients, it is not
known if the same results could be achieved in someone who
is morbid/super obese with high ASA and multiple co-morbid-
ities. For example, performing a LC in an obese patient suffer-
ing from obstructive sleep apnoea can be challenging from the
respiratory system point of view, especially if prolonged insuf-
flation with CO2 is required. Second, the follow-up duration
was only up to 8 weeks post-operatively; therefore, long-term
(e.g. 6- or 12-months) data such as the incidence of incisional
hernia or resolution of symptoms is unknown. A longer fol-
low-up could also reveal how well and how soon before the
patient could return to their normal daily routine or work.
Lastly the authors acknowledge the small number of patients
in the morbid and super obese groups. However, to the
authors’ knowledge, this study reported the second largest
number of morbid/super obese (BMI > 40) patients in the lit-
erature after Khan et al.9 Therefore, the authors believe that
this study provides important data on the safety and efficacy
of LC in the morbid/super obese patients. Overall only four
(0.5%) patients suffered a BDI which provides the reassurance
that LC is a safe procedure consistent with other figures in the
literature. While the total number of morbid/super obese
patients was small (n = 76), no patient in this groups suffered
a bile duct injury. The authors calculated the sample size
required to detect statistically significant differences based on
Table 3 Peri-operative complications
BMI <26 n = 170 26–40 n = 553 >40 n = 76 Total N = 799
Dindo–Clavien grading, n (%)
I 4 (2.4) 3 (0.5) 3 (3.8) 10 (1.3)
II 2 (1.2) 8 (1.4) 1 (1.3) 11 (1.4)
IIIa 0 (0.0) 5 (0.9) 0 (0.0) 5 (0.6)
IIIb 1 (0.6) 8 (1.4) 2 (2.6) 11 (1.4)
IV a 1 (0.6) 1 (0.2) 0 (0.0) 2 (0.3)
IV b 0 (0.0) 0 (0.0) 0 (0.0) 0 (0)
V 0 (0.0) 1 (0.2) 0 (0.0) 1 (0.1)
Minor- grade I & II, n (%)
Pain 3 (1.8) 3 (0.5) 1 (1.3) 7 (0.9)
Port site infection 1 (0.6) 6 (1.1) 2 (2.6) 8 (1.0)
ARF 0 (0.0) 0 (0.0) 1 (1.3) 1 (0.1)
Collection 0 (0.0) 2 (0.4) 0 (0.0) 2 (0.3)
DVT 0 (0.0) 0 (0.0) 1 (1.3) 1 (0.1)
Port site bleeding 1 (0.6) 0 (0.0) 0 (0.0) 1 (0.1)
Delirium 1 (0.6) 0 (0.0) 0 (0.0) 1 (0.1)
Major – grade III/IV/V, n (%)
Choledocholithiasis/pancreatitis 0 (0.0) 3 (0.5) 1 (1.3) 4 (0.5)
Bile leak 0 (0.0) 3 (0.5) 0 (0.0) 3 (0.4)
Bleeding 1 (0.6) 2 (0.4) 0 (0.0) 3 (0.4)
Collection 0 (0.0) 3 (0.5) 0 (0.0) 3 (0.4)
Papillary Stenosis 0 (0.0) 1 (0.2) 0 (0.0) 1 (0.1)
Respiratory distress/acidosis 1 (0.6) 0 (0.0) 0 (0.0) 1 (0.1)
Deranged LFT/ERCP 0 (0.0) 1 (0.2) 0 (0.0) 1 (0.1)
Mortality 0 (0.0) 1 (0.2) 0 (0.0) 1 (0.1)
ARF, acute renal failure; DVT, deep vein thrombosis; LFT, liver functioning test; ERCP, endoscopic retrograde cholangiopancreatography.
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the data from this study; using an alpha value (P-value) of
0.05 and power of 0.8. For biliary complications, the number
of patients needed to detect a significant odds ratio of 0.5 is
4267 people per group. This means that just comparing the
rate of BDI in two groups of patients would require 8534
patients. These figures are very difficult to achieve even in
multi-centre studies, and the authors believed a meta-analysis
or a population-based registry might be the only way to
achieve this. Therefore, with the results of this study the
authors hope to add additional data to the growing evidence
in the literature that LC in this group of patients is safe.
Conclusion
This study has shown that LC can be performed safely in the
morbid and super obese patients and with the same favourable
outcomes as seen in those patients with a normal BMI. There-
fore, LC should be considered as the gold standard treatment for
the morbid and super obese patients with symptomatic choleli-
thiasis.
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